EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of an Ultrasensitive ELISA Assay for Evaluating HIV-1 Envelope Glycoprotein as a Marker for Targeted Activator of Cell Kill

Guoxin Wu, Luca Sardo, Yuan Li, Steven D Heron iD, BaoJen Shyong, Matthew Mazur iD, Daniel M Gorman, Carl J Balibar iD, Brian C Magliaro, Craig Leach, Thomas Rush, Bonnie J Howell iD

Viruses · 2025

DOI: 10.3390/v18010046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Guoxin Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: MRL, Merck & Co., Inc., Rahway, NJ 07065, USA. Hauptthemen laut MEDLINE: HIV Envelope Protein gp120, HIV-1, HIV Infections. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The HIV-1 envelope glycoprotein gp120 is prominently exposed on the surface of both HIV-1 virions and infected host cells, serving as a key marker of infection. gp120 plays a pivotal role in viral entry by interacting with the primary receptor, CD4, on host cells. Therapeutic strategies targeting the HIV-1 reservoir, such as anti-gp120 antibodies that trigger antibody-dependent cellular cytotoxicity (ADCC) and chimeric antigen receptor T (CAR-T) cells, rely on the presence of gp120 on the surface of infected cells to exert their effects. Consequently, accurate monitoring of gp120 expression on infected cells is essential for evaluating the pharmacological efficacy of these interventions. In this study, a sensitive, specific, and inexpensive enzyme-linked immunosorbent assay (ELISA) for quantifying HIV-1 gp120 glycoprotein was developed using a selected pair of anti-gp120 antibodies. The assay achieved a lower limit of quantitation (LLOQ) of 0.16 pM, demonstrating sensitivity comparable to that of the digital single molecule array (Simoa) platform, which exhibited a LLOQ of 0.23 pM and requires specialized instrumentation. The binding specificity of the antibodies used in the novel assay was confirmed using liquid chromatography–mass spectrometry (LC-MS), and the assay was pharmacologically validated with lysates obtained from 2D10 and MOLT IIIB cell lines. Furthermore, treatment of HIV-infected human primary CD4+ T cells with a targeted activator of cell kill (TACK) compound significantly reduced gp120 concentration in CD4+ T cell lysate compared to controls. The gp120 marker from infected cell lysates correlated with the number of gp120-positive cells detected by immunocytochemistry, as well as with HIV-1 p24 levels and cell-associated viral RNA measurements. In summary, a novel, simple, and sensitive HIV-1 gp120 ELISA has been developed and validated. This assay holds potential for investigating HIV-1 persistence and evaluating the efficacy of therapeutic agents targeting infected cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV Envelope Protein gp120HIV-1HIV InfectionsHumansEnzyme-Linked Immunosorbent AssaySensitivity and SpecificityHIV AntibodiesBiomarkersAntibody-Dependent Cell CytotoxicityCell Line

Stichwörter der Autor:innen

ELISAHIV-1QuanterixTACKantibodybiomarkergp120immunocytochemistrymass spectrometry (MS)

Substanzen

HIV Envelope Protein gp120gp120 protein, Human immunodeficiency virus 1HIV AntibodiesBiomarkers

Autor:innen und Institutionen

  • MRL, Merck & Co., Inc., Rahway, NJ 07065, USA.
  • Eurofins Professional Scientific Services Mid Atlantic, LLC, Lancaster, PA 17601, USA.

ORCID-Profile: Steven D Heron, Matthew Mazur, Carl J Balibar, Bonnie J Howell

Zitieren

APA

Wu, G., Sardo, L., Li, Y., Heron, S. D., Shyong, B., Mazur, M., Gorman, D. M., Balibar, C. J., Magliaro, B. C., Leach, C., Rush, T., & Howell, B. J. (2025). Development of an Ultrasensitive ELISA Assay for Evaluating HIV-1 Envelope Glycoprotein as a Marker for Targeted Activator of Cell Kill. Viruses. https://doi.org/10.3390/v18010046

Vancouver

Wu G, Sardo L, Li Y, Heron SD, Shyong B, Mazur M, et al. Development of an Ultrasensitive ELISA Assay for Evaluating HIV-1 Envelope Glycoprotein as a Marker for Targeted Activator of Cell Kill. Viruses. 2025. doi:10.3390/v18010046

BibTeX
@article{Wu2025,
  author = {Wu, Guoxin and Sardo, Luca and Li, Yuan and Heron, Steven D and Shyong, BaoJen and Mazur, Matthew and Gorman, Daniel M and Balibar, Carl J and Magliaro, Brian C and Leach, Craig and Rush, Thomas and Howell, Bonnie J},
  title = {Development of an Ultrasensitive ELISA Assay for Evaluating HIV-1 Envelope Glycoprotein as a Marker for Targeted Activator of Cell Kill},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v18010046}
}
Kostenlos starten →